Latest Breaking News On - Hypoactive sexual desire disorder - Page 7 : comparemela.com

Skeptic » Reading Room » Big Pharma s Cynical Search for a Female Sex Drug

Skeptic » Reading Room » Big Pharma s Cynical Search for a Female Sex Drug
skeptic.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from skeptic.com Daily Mail and Mail on Sunday newspapers.

United statesCarol tavrisLeonore tieferElliot aronsonLife healthFoundation for criticalBoehringer ingelheimAssociation for psychological scienceSimmons collegePreview campaignWomen health initiativeProcter gambleValeant pharmaceuticalsInquiry independent investigations groupBig pharmaHoly grail

Palatin Announces Preliminary Fourth Quarter Vyleesi® Net Product Revenue Increased 225% Over Prior Quarter

/PRNewswire/ Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that.

Ch ungch ong buktoSouth koreaUnited statesCarl spanaFosun pharmaExchange commissionPalatin technologies incKwangdong pharmaceuticalsSecurities exchangeDrug administrationPalatin technologiesHypoactive sexual desire disorderNorth americaSecurities actSecurities exchange actPrivate securities litigation reform act

The Illusion of Evidence-Based Medicine

On the rotten state of evidence-baded medicine, and whether there is any way out.

United statesUnited kingdomRichard dollKarl popperEli lillyBradford hillGabapentin neurontinVannevar bushJon jureidiniLeemonb mchenryRofecoxcib vioxxJames lindFrances oldham kelseyAmerica phAmerican heart associationPurdue pharma

Palatin Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update

Patient Enrollment on Track in Phase 3 Pivotal Study of PL9643 in Patients with Dry Eye Disease with Topline Results Currently Expected Second Half Calendar.

United statesCarl spanaExchange commissionPalatin technologies incPrnewswire palatin technologies incSecurities exchangeAssociation for researchColitis congressPatient enrollmentDry eye diseasePrivate placementConvertible redeemable preferred stockUlcerative colitis expectedStart next monthQuarter ended fiscal yearHypoactive sexual desire disorder

Memorial Sloan Kettering Cancer Center (MSK) Shares Positive Preliminary Results of Flibanserin in Breast Cancer Patients Suffering from Low Libido

70% of women diagnosed with breast cancer report having sexual dysfunction; there are currently a lack of effective treatment options for these wo.

United statesCindy eckertShari goldfarbSloan ketteringAmerican society of clinical oncologySprout pharmaceuticalsSprout pharmaceuticals incMemorial sloan kettering cancer centerHypoactive sexual desire disorderAnnual meetingInternational societySexual healthAmerican societyClinical oncologyMemorial sloan kettering cancerFemale sexual function index